UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057480
Receipt number R000065674
Scientific Title Amino Acid Concentration in Blood at Consumption of Test Food and Safety Confirmation Study
Date of disclosure of the study information 2025/04/01
Last modified on 2025/04/01 14:52:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Amino Acid Concentration in Blood at Consumption of Test Food and Safety Confirmation Study

Acronym

Amino Acid Concentration in Blood at Consumption of Test Food and Safety Confirmation Study

Scientific Title

Amino Acid Concentration in Blood at Consumption of Test Food and Safety Confirmation Study

Scientific Title:Acronym

Amino Acid Concentration in Blood at Consumption of Test Food and Safety Confirmation Study

Region

Japan


Condition

Condition

Health Volunteers

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To study the absorption and safety of amino acids in the body when ingesting three test foods.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in blood amino acids

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Protein.1

Interventions/Control_2

Protein.2

Interventions/Control_3

Protein.3

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1.Japanese men and women aged 20 to 60 years old at the time of obtaining consent

2.Those with a BMI of 18.5 kg/m2 or more and less than 25.0 kg/m2 at screening

3.Those with a systolic blood pressure of less than 140 mmHg and a diastolic blood pressure of less than 90 mmHg at screening

4.Those who agree to participate in the study and can sign and date the consent form themselves

Key exclusion criteria

1.Those with a serious medical history or a history of gastrointestinal resection (excluding appendectomy and endoscopic polypectomy).
2.Those with a disease that affects excretion and digestion/absorption, or those who regularly experience indigestion, constipation, diarrhea, etc.
3.Those with significantly abnormal values in blood pressure and indices of kidney function, liver function, glucose metabolism, and lipid metabolism.
4.Those who regularly use internal medicines and supplements.
5.Those who drink a lot of alcohol (more than 60g of pure alcohol per day) and those who smoke excessively (more than 20 cigarettes per day) (including those who cannot quit smoking during the time frame of their visit or cannot maintain normal mind and body by quitting smoking).
6.Those who are taking other foods, taking medicines, or applying cosmetics or quasi-drugs, or those who are participating in an intervention study or plan to participate in another study during this study.
7.Those who have donated 400mL of blood within 6 months prior to this study.
8.Those who cannot eat any food, including the test food or the standardized diet, due to food allergies or disliked ingredients.
9.Those who may be unable to ingest ingredients in the test food whose origin is not clearly stated due to religious or other reasons.
10.Those who are otherwise deemed inappropriate to participate in this study by the principal investigator.

Target sample size

21


Research contact person

Name of lead principal investigator

1st name Teramoto
Middle name
Last name Sachiyuki

Organization

FANCL

Division name

Research Institute

Zip code

244 0806

Address

12-13 Shinano, Totsuka-ku, Yokohama, Kanagawa Prefecture

TEL

09014218080

Email

tsubokawa_masaya@fancl.co.jp


Public contact

Name of contact person

1st name Tsubokawa
Middle name
Last name Masaya

Organization

FANCL

Division name

clinical trial group

Zip code

244 0806

Address

12-13 Shinano, Totsuka-ku, Yokohama, Kanagawa Prefecture

TEL

09014218080

Homepage URL


Email

tsubokawa_masaya@fancl.co.jp


Sponsor or person

Institute

FANCL

Institute

Department

Personal name



Funding Source

Organization

FANCL

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamazaki Otorhinolaryngology Clinic Ethics Review Committee

Address

Kita 11-jo Nishi 14-1-16, Chuo-ku, Sapporo, Hokkaido

Tel

011-757-3387

Email

i-takehara@kyowa-t.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 02 Month 18 Day

Date of IRB


Anticipated trial start date

2025 Year 04 Month 05 Day

Last follow-up date

2025 Year 04 Month 19 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 04 Month 01 Day

Last modified on

2025 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065674